Prefilled Syringes Market - Top Companies and Manufacturers

  • Report ID: 4398
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Companies Dominating the Prefilled Syringes Landscape

top-features-companies
    • Abbott
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Bayer Pharmaceuticals
    • Baxter BioPharma Solutions
    • BG (Becton, Dickinson and Company)
    • Gerresheimer AG
    • Medtronic
    • Nipro Pharma Corporation
    • Terumo Medical Corporation
    • Vetter Pharma International GmbH
    • West Pharmaceutical Services, Inc.

Browse Key Market Insights with Data Illustration:

In the News

  •  Baxter BioPharma Solutions a pioneer in the delivery and production of sterile drugs expanded its sterile fill/finish manufacturing facilities located in Bloomington, Ind. Further, a high-speed automated syringe fills line with a fill rate of up to 600 units per minute, and a new high-speed automated visual inspection line were all part of the facility's planned infrastructure expansion.

  • BG (Becton, Dickinson and Company) introduced BD Effivax Glass Prefillable Syringe to establish a new benchmark for vaccine PFS performance. Further, it is expected to provide clients with additional support to handle the demanding requirements of today's vaccine manufacturing through design improvements targeted at fill/finish and container dependability.

 


Author Credits:  Radhika Pawar


  • Report ID: 4398
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of prefilled syringes is estimated at USD 17.82 Billion.

The prefilled syringes market size was valued at USD 15.89 Billion in 2023 and is poised to cross USD 82.43 Billion by the end of 2036, registering more than 13.5% CAGR during the forecast period i.e., between 2024-2036. Increasing prevalence of HIV and hepatitis-B cases and the rise in demand of self-injection devices are the major factors driving the market growth.

Europe is predicted to be the largest with a share of about 41% by 2036, attributed to increasing geriatric population.

Abbott, Bayer Pharmaceuticals, Baxter BioPharma Solutions, BG (Becton, Dickinson and Company), Gerresheimer AG, Medtronic, Nipro Pharma Corporation, Terumo Medical Corporation, Vetter Pharma International GmbH, West Pharmaceutical Services, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying